nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethoprim—TYMS—ovarian cancer	0.472	0.798	CbGaD
Trimethoprim—ABCB1—ovarian cancer	0.12	0.202	CbGaD
Trimethoprim—ABCB1—Topotecan—ovarian cancer	0.0355	0.174	CbGbCtD
Trimethoprim—CYP2C8—Paclitaxel—ovarian cancer	0.0259	0.127	CbGbCtD
Trimethoprim—ABCB1—Vinorelbine—ovarian cancer	0.025	0.122	CbGbCtD
Trimethoprim—CYP3A4—Topotecan—ovarian cancer	0.0213	0.104	CbGbCtD
Trimethoprim—CYP2C9—Paclitaxel—ovarian cancer	0.0181	0.0886	CbGbCtD
Trimethoprim—ABCB1—Paclitaxel—ovarian cancer	0.0176	0.086	CbGbCtD
Trimethoprim—CYP3A4—Vinorelbine—ovarian cancer	0.015	0.0733	CbGbCtD
Trimethoprim—ABCB1—Docetaxel—ovarian cancer	0.0127	0.0622	CbGbCtD
Trimethoprim—CYP3A4—Paclitaxel—ovarian cancer	0.0105	0.0515	CbGbCtD
Trimethoprim—ABCB1—Doxorubicin—ovarian cancer	0.00946	0.0463	CbGbCtD
Trimethoprim—CYP3A4—Docetaxel—ovarian cancer	0.00761	0.0372	CbGbCtD
Trimethoprim—CYP3A4—Doxorubicin—ovarian cancer	0.00567	0.0278	CbGbCtD
Trimethoprim—DHFR—myometrium—ovarian cancer	0.00182	0.0572	CbGeAlD
Trimethoprim—DHFR—embryo—ovarian cancer	0.00175	0.055	CbGeAlD
Trimethoprim—TYMS—Docetaxel—Paclitaxel—ovarian cancer	0.00167	0.472	CbGdCrCtD
Trimethoprim—TYMS—uterine cervix—ovarian cancer	0.00143	0.045	CbGeAlD
Trimethoprim—DHFR—uterine cervix—ovarian cancer	0.00142	0.0445	CbGeAlD
Trimethoprim—DHFR—decidua—ovarian cancer	0.00135	0.0424	CbGeAlD
Trimethoprim—TYMS—endometrium—ovarian cancer	0.00129	0.0407	CbGeAlD
Trimethoprim—DHFR—endometrium—ovarian cancer	0.00128	0.0403	CbGeAlD
Trimethoprim—TYMS—gonad—ovarian cancer	0.0012	0.0377	CbGeAlD
Trimethoprim—DHFR—gonad—ovarian cancer	0.00119	0.0374	CbGeAlD
Trimethoprim—DHFR—uterus—ovarian cancer	0.00118	0.0371	CbGeAlD
Trimethoprim—TYMS—female reproductive system—ovarian cancer	0.00107	0.0337	CbGeAlD
Trimethoprim—DHFR—female reproductive system—ovarian cancer	0.00106	0.0334	CbGeAlD
Trimethoprim—TYMS—bone marrow—ovarian cancer	0.00101	0.0318	CbGeAlD
Trimethoprim—DHFR—bone marrow—ovarian cancer	0.001	0.0315	CbGeAlD
Trimethoprim—TYMS—female gonad—ovarian cancer	0.000976	0.0307	CbGeAlD
Trimethoprim—TYMS—vagina—ovarian cancer	0.00097	0.0305	CbGeAlD
Trimethoprim—DHFR—female gonad—ovarian cancer	0.000966	0.0304	CbGeAlD
Trimethoprim—DHFR—vagina—ovarian cancer	0.00096	0.0302	CbGeAlD
Trimethoprim—TYMS—testis—ovarian cancer	0.000866	0.0272	CbGeAlD
Trimethoprim—DHFR—testis—ovarian cancer	0.000857	0.0269	CbGeAlD
Trimethoprim—TYMS—Paclitaxel—Docetaxel—ovarian cancer	0.000832	0.236	CbGdCrCtD
Trimethoprim—CYP2C8—endometrium—ovarian cancer	0.000636	0.02	CbGeAlD
Trimethoprim—TYMS—lymph node—ovarian cancer	0.000627	0.0197	CbGeAlD
Trimethoprim—DHFR—lymph node—ovarian cancer	0.000621	0.0195	CbGeAlD
Trimethoprim—TYMS—Vincristine—Vinorelbine—ovarian cancer	0.000572	0.162	CbGdCrCtD
Trimethoprim—CYP2C8—female reproductive system—ovarian cancer	0.000527	0.0166	CbGeAlD
Trimethoprim—CYP2C8—vagina—ovarian cancer	0.000477	0.015	CbGeAlD
Trimethoprim—CYP2C9—female reproductive system—ovarian cancer	0.000468	0.0147	CbGeAlD
Trimethoprim—TYMS—Vinblastine—Vinorelbine—ovarian cancer	0.00046	0.13	CbGdCrCtD
Trimethoprim—ABCB1—myometrium—ovarian cancer	0.000433	0.0136	CbGeAlD
Trimethoprim—CYP2C8—testis—ovarian cancer	0.000425	0.0134	CbGeAlD
Trimethoprim—ABCB1—embryo—ovarian cancer	0.000417	0.0131	CbGeAlD
Trimethoprim—CYP3A4—female reproductive system—ovarian cancer	0.000357	0.0112	CbGeAlD
Trimethoprim—ABCB1—epithelium—ovarian cancer	0.00034	0.0107	CbGeAlD
Trimethoprim—ABCB1—uterine cervix—ovarian cancer	0.000337	0.0106	CbGeAlD
Trimethoprim—ABCB1—decidua—ovarian cancer	0.000321	0.0101	CbGeAlD
Trimethoprim—ABCB1—endometrium—ovarian cancer	0.000305	0.00959	CbGeAlD
Trimethoprim—ABCB1—gonad—ovarian cancer	0.000283	0.00889	CbGeAlD
Trimethoprim—ABCB1—uterus—ovarian cancer	0.000281	0.00883	CbGeAlD
Trimethoprim—ABCB1—female reproductive system—ovarian cancer	0.000253	0.00794	CbGeAlD
Trimethoprim—ABCB1—bone marrow—ovarian cancer	0.000239	0.0075	CbGeAlD
Trimethoprim—ABCB1—female gonad—ovarian cancer	0.00023	0.00723	CbGeAlD
Trimethoprim—ABCB1—vagina—ovarian cancer	0.000229	0.00718	CbGeAlD
Trimethoprim—ABCB1—testis—ovarian cancer	0.000204	0.00641	CbGeAlD
Trimethoprim—Connective tissue disorder—Docetaxel—ovarian cancer	0.000177	0.00154	CcSEcCtD
Trimethoprim—Urethral disorder—Docetaxel—ovarian cancer	0.000177	0.00153	CcSEcCtD
Trimethoprim—Hyponatraemia—Epirubicin—ovarian cancer	0.000177	0.00153	CcSEcCtD
Trimethoprim—Diarrhoea—Melphalan—ovarian cancer	0.000176	0.00153	CcSEcCtD
Trimethoprim—Nausea—Chlorambucil—ovarian cancer	0.000176	0.00152	CcSEcCtD
Trimethoprim—Dizziness—Topotecan—ovarian cancer	0.000174	0.00151	CcSEcCtD
Trimethoprim—Tremor—Paclitaxel—ovarian cancer	0.000174	0.0015	CcSEcCtD
Trimethoprim—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.000173	0.00149	CcSEcCtD
Trimethoprim—Renal impairment—Doxorubicin—ovarian cancer	0.000171	0.00148	CcSEcCtD
Trimethoprim—Erythema multiforme—Docetaxel—ovarian cancer	0.000171	0.00148	CcSEcCtD
Trimethoprim—Dermatitis bullous—Doxorubicin—ovarian cancer	0.00017	0.00147	CcSEcCtD
Trimethoprim—Agitation—Paclitaxel—ovarian cancer	0.00017	0.00147	CcSEcCtD
Trimethoprim—Angioedema—Paclitaxel—ovarian cancer	0.000169	0.00147	CcSEcCtD
Trimethoprim—Purpura—Doxorubicin—ovarian cancer	0.000169	0.00146	CcSEcCtD
Trimethoprim—Eye disorder—Docetaxel—ovarian cancer	0.000169	0.00146	CcSEcCtD
Trimethoprim—Vomiting—Topotecan—ovarian cancer	0.000167	0.00145	CcSEcCtD
Trimethoprim—Hypoglycaemia—Doxorubicin—ovarian cancer	0.000167	0.00144	CcSEcCtD
Trimethoprim—Vertigo—Paclitaxel—ovarian cancer	0.000167	0.00144	CcSEcCtD
Trimethoprim—Syncope—Paclitaxel—ovarian cancer	0.000166	0.00144	CcSEcCtD
Trimethoprim—Lethargy—Doxorubicin—ovarian cancer	0.000166	0.00144	CcSEcCtD
Trimethoprim—Leukopenia—Paclitaxel—ovarian cancer	0.000166	0.00144	CcSEcCtD
Trimethoprim—Rash—Topotecan—ovarian cancer	0.000166	0.00144	CcSEcCtD
Trimethoprim—Hypersensitivity—Vinorelbine—ovarian cancer	0.000166	0.00143	CcSEcCtD
Trimethoprim—Dermatitis—Topotecan—ovarian cancer	0.000166	0.00143	CcSEcCtD
Trimethoprim—Ataxia—Epirubicin—ovarian cancer	0.000166	0.00143	CcSEcCtD
Trimethoprim—Headache—Topotecan—ovarian cancer	0.000165	0.00143	CcSEcCtD
Trimethoprim—Vomiting—Melphalan—ovarian cancer	0.000164	0.00142	CcSEcCtD
Trimethoprim—Hyponatraemia—Doxorubicin—ovarian cancer	0.000164	0.00142	CcSEcCtD
Trimethoprim—Immune system disorder—Docetaxel—ovarian cancer	0.000163	0.00141	CcSEcCtD
Trimethoprim—Loss of consciousness—Paclitaxel—ovarian cancer	0.000163	0.00141	CcSEcCtD
Trimethoprim—Mediastinal disorder—Docetaxel—ovarian cancer	0.000163	0.00141	CcSEcCtD
Trimethoprim—Rash—Melphalan—ovarian cancer	0.000162	0.00141	CcSEcCtD
Trimethoprim—Dermatitis—Melphalan—ovarian cancer	0.000162	0.0014	CcSEcCtD
Trimethoprim—Cough—Paclitaxel—ovarian cancer	0.000162	0.0014	CcSEcCtD
Trimethoprim—Convulsion—Paclitaxel—ovarian cancer	0.000161	0.00139	CcSEcCtD
Trimethoprim—Pruritus—Vinorelbine—ovarian cancer	0.000159	0.00138	CcSEcCtD
Trimethoprim—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.000159	0.00137	CcSEcCtD
Trimethoprim—Mental disorder—Docetaxel—ovarian cancer	0.000158	0.00137	CcSEcCtD
Trimethoprim—Myalgia—Paclitaxel—ovarian cancer	0.000158	0.00137	CcSEcCtD
Trimethoprim—Arthralgia—Paclitaxel—ovarian cancer	0.000158	0.00137	CcSEcCtD
Trimethoprim—Anxiety—Paclitaxel—ovarian cancer	0.000157	0.00136	CcSEcCtD
Trimethoprim—Erythema—Docetaxel—ovarian cancer	0.000157	0.00136	CcSEcCtD
Trimethoprim—Malnutrition—Docetaxel—ovarian cancer	0.000157	0.00136	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000157	0.00136	CcSEcCtD
Trimethoprim—Nausea—Topotecan—ovarian cancer	0.000156	0.00135	CcSEcCtD
Trimethoprim—Diarrhoea—Vinorelbine—ovarian cancer	0.000154	0.00133	CcSEcCtD
Trimethoprim—Ataxia—Doxorubicin—ovarian cancer	0.000153	0.00133	CcSEcCtD
Trimethoprim—Nausea—Melphalan—ovarian cancer	0.000153	0.00132	CcSEcCtD
Trimethoprim—Confusional state—Paclitaxel—ovarian cancer	0.000153	0.00132	CcSEcCtD
Trimethoprim—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000151	0.00131	CcSEcCtD
Trimethoprim—Eosinophilia—Epirubicin—ovarian cancer	0.000151	0.0013	CcSEcCtD
Trimethoprim—Pancreatitis—Epirubicin—ovarian cancer	0.000149	0.00129	CcSEcCtD
Trimethoprim—Shock—Paclitaxel—ovarian cancer	0.000149	0.00129	CcSEcCtD
Trimethoprim—Dizziness—Vinorelbine—ovarian cancer	0.000149	0.00129	CcSEcCtD
Trimethoprim—Nervous system disorder—Paclitaxel—ovarian cancer	0.000148	0.00128	CcSEcCtD
Trimethoprim—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000148	0.00128	CcSEcCtD
Trimethoprim—ABCB1—lymph node—ovarian cancer	0.000148	0.00465	CbGeAlD
Trimethoprim—Skin disorder—Paclitaxel—ovarian cancer	0.000147	0.00127	CcSEcCtD
Trimethoprim—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.000147	0.00127	CcSEcCtD
Trimethoprim—Pancytopenia—Epirubicin—ovarian cancer	0.000145	0.00125	CcSEcCtD
Trimethoprim—Anorexia—Paclitaxel—ovarian cancer	0.000144	0.00125	CcSEcCtD
Trimethoprim—Vomiting—Vinorelbine—ovarian cancer	0.000143	0.00124	CcSEcCtD
Trimethoprim—Neutropenia—Epirubicin—ovarian cancer	0.000142	0.00123	CcSEcCtD
Trimethoprim—Rash—Vinorelbine—ovarian cancer	0.000142	0.00123	CcSEcCtD
Trimethoprim—Dermatitis—Vinorelbine—ovarian cancer	0.000142	0.00123	CcSEcCtD
Trimethoprim—Headache—Vinorelbine—ovarian cancer	0.000141	0.00122	CcSEcCtD
Trimethoprim—Syncope—Docetaxel—ovarian cancer	0.000141	0.00122	CcSEcCtD
Trimethoprim—Leukopenia—Docetaxel—ovarian cancer	0.000141	0.00122	CcSEcCtD
Trimethoprim—Eosinophilia—Doxorubicin—ovarian cancer	0.000139	0.00121	CcSEcCtD
Trimethoprim—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000139	0.0012	CcSEcCtD
Trimethoprim—Loss of consciousness—Docetaxel—ovarian cancer	0.000138	0.0012	CcSEcCtD
Trimethoprim—Pancreatitis—Doxorubicin—ovarian cancer	0.000138	0.00119	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000138	0.00119	CcSEcCtD
Trimethoprim—Cough—Docetaxel—ovarian cancer	0.000137	0.00119	CcSEcCtD
Trimethoprim—Insomnia—Paclitaxel—ovarian cancer	0.000137	0.00118	CcSEcCtD
Trimethoprim—Pneumonia—Epirubicin—ovarian cancer	0.000136	0.00118	CcSEcCtD
Trimethoprim—Convulsion—Docetaxel—ovarian cancer	0.000136	0.00118	CcSEcCtD
Trimethoprim—Infestation NOS—Epirubicin—ovarian cancer	0.000136	0.00117	CcSEcCtD
Trimethoprim—Infestation—Epirubicin—ovarian cancer	0.000136	0.00117	CcSEcCtD
Trimethoprim—Dyspnoea—Paclitaxel—ovarian cancer	0.000135	0.00117	CcSEcCtD
Trimethoprim—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000135	0.00116	CcSEcCtD
Trimethoprim—Myalgia—Docetaxel—ovarian cancer	0.000134	0.00116	CcSEcCtD
Trimethoprim—Arthralgia—Docetaxel—ovarian cancer	0.000134	0.00116	CcSEcCtD
Trimethoprim—Pancytopenia—Doxorubicin—ovarian cancer	0.000134	0.00116	CcSEcCtD
Trimethoprim—Nausea—Vinorelbine—ovarian cancer	0.000134	0.00116	CcSEcCtD
Trimethoprim—Renal failure—Epirubicin—ovarian cancer	0.000133	0.00115	CcSEcCtD
Trimethoprim—Dyspepsia—Paclitaxel—ovarian cancer	0.000133	0.00115	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000133	0.00115	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000133	0.00115	CcSEcCtD
Trimethoprim—Stomatitis—Epirubicin—ovarian cancer	0.000132	0.00114	CcSEcCtD
Trimethoprim—Neutropenia—Doxorubicin—ovarian cancer	0.000132	0.00114	CcSEcCtD
Trimethoprim—Decreased appetite—Paclitaxel—ovarian cancer	0.000132	0.00114	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000131	0.00113	CcSEcCtD
Trimethoprim—Constipation—Paclitaxel—ovarian cancer	0.000129	0.00112	CcSEcCtD
Trimethoprim—Haematuria—Epirubicin—ovarian cancer	0.000129	0.00112	CcSEcCtD
Trimethoprim—Confusional state—Docetaxel—ovarian cancer	0.000129	0.00112	CcSEcCtD
Trimethoprim—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000129	0.00111	CcSEcCtD
Trimethoprim—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000128	0.00111	CcSEcCtD
Trimethoprim—Anaphylactic shock—Docetaxel—ovarian cancer	0.000128	0.00111	CcSEcCtD
Trimethoprim—Epistaxis—Epirubicin—ovarian cancer	0.000128	0.00111	CcSEcCtD
Trimethoprim—Agranulocytosis—Epirubicin—ovarian cancer	0.000127	0.0011	CcSEcCtD
Trimethoprim—Pneumonia—Doxorubicin—ovarian cancer	0.000126	0.00109	CcSEcCtD
Trimethoprim—Shock—Docetaxel—ovarian cancer	0.000126	0.00109	CcSEcCtD
Trimethoprim—Nervous system disorder—Docetaxel—ovarian cancer	0.000126	0.00109	CcSEcCtD
Trimethoprim—Thrombocytopenia—Docetaxel—ovarian cancer	0.000126	0.00109	CcSEcCtD
Trimethoprim—Infestation NOS—Doxorubicin—ovarian cancer	0.000126	0.00109	CcSEcCtD
Trimethoprim—Infestation—Doxorubicin—ovarian cancer	0.000126	0.00109	CcSEcCtD
Trimethoprim—Feeling abnormal—Paclitaxel—ovarian cancer	0.000125	0.00108	CcSEcCtD
Trimethoprim—Skin disorder—Docetaxel—ovarian cancer	0.000125	0.00108	CcSEcCtD
Trimethoprim—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000124	0.00108	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000124	0.00107	CcSEcCtD
Trimethoprim—Renal failure—Doxorubicin—ovarian cancer	0.000123	0.00107	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000123	0.00106	CcSEcCtD
Trimethoprim—Stomatitis—Doxorubicin—ovarian cancer	0.000122	0.00106	CcSEcCtD
Trimethoprim—Anorexia—Docetaxel—ovarian cancer	0.000122	0.00106	CcSEcCtD
Trimethoprim—Urinary tract disorder—Epirubicin—ovarian cancer	0.00012	0.00104	CcSEcCtD
Trimethoprim—Urticaria—Paclitaxel—ovarian cancer	0.00012	0.00104	CcSEcCtD
Trimethoprim—Haematuria—Doxorubicin—ovarian cancer	0.00012	0.00104	CcSEcCtD
Trimethoprim—Connective tissue disorder—Epirubicin—ovarian cancer	0.00012	0.00104	CcSEcCtD
Trimethoprim—Body temperature increased—Paclitaxel—ovarian cancer	0.00012	0.00104	CcSEcCtD
Trimethoprim—Abdominal pain—Paclitaxel—ovarian cancer	0.00012	0.00104	CcSEcCtD
Trimethoprim—Urethral disorder—Epirubicin—ovarian cancer	0.000119	0.00103	CcSEcCtD
Trimethoprim—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000119	0.00103	CcSEcCtD
Trimethoprim—Epistaxis—Doxorubicin—ovarian cancer	0.000118	0.00102	CcSEcCtD
Trimethoprim—Agranulocytosis—Doxorubicin—ovarian cancer	0.000117	0.00101	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000117	0.00101	CcSEcCtD
Trimethoprim—Insomnia—Docetaxel—ovarian cancer	0.000116	0.001	CcSEcCtD
Trimethoprim—Erythema multiforme—Epirubicin—ovarian cancer	0.000115	0.000997	CcSEcCtD
Trimethoprim—Dyspnoea—Docetaxel—ovarian cancer	0.000114	0.00099	CcSEcCtD
Trimethoprim—Eye disorder—Epirubicin—ovarian cancer	0.000114	0.000985	CcSEcCtD
Trimethoprim—Tinnitus—Epirubicin—ovarian cancer	0.000114	0.000983	CcSEcCtD
Trimethoprim—Dyspepsia—Docetaxel—ovarian cancer	0.000113	0.000977	CcSEcCtD
Trimethoprim—Decreased appetite—Docetaxel—ovarian cancer	0.000112	0.000965	CcSEcCtD
Trimethoprim—Hypersensitivity—Paclitaxel—ovarian cancer	0.000112	0.000965	CcSEcCtD
Trimethoprim—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000111	0.000963	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000111	0.000958	CcSEcCtD
Trimethoprim—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000111	0.000958	CcSEcCtD
Trimethoprim—Urethral disorder—Doxorubicin—ovarian cancer	0.00011	0.000956	CcSEcCtD
Trimethoprim—Immune system disorder—Epirubicin—ovarian cancer	0.00011	0.000952	CcSEcCtD
Trimethoprim—Mediastinal disorder—Epirubicin—ovarian cancer	0.00011	0.00095	CcSEcCtD
Trimethoprim—Constipation—Docetaxel—ovarian cancer	0.00011	0.000949	CcSEcCtD
Trimethoprim—Pruritus—Paclitaxel—ovarian cancer	0.000107	0.000927	CcSEcCtD
Trimethoprim—Mental disorder—Epirubicin—ovarian cancer	0.000107	0.000923	CcSEcCtD
Trimethoprim—Erythema multiforme—Doxorubicin—ovarian cancer	0.000107	0.000922	CcSEcCtD
Trimethoprim—Erythema—Epirubicin—ovarian cancer	0.000106	0.000918	CcSEcCtD
Trimethoprim—Malnutrition—Epirubicin—ovarian cancer	0.000106	0.000918	CcSEcCtD
Trimethoprim—Feeling abnormal—Docetaxel—ovarian cancer	0.000106	0.000915	CcSEcCtD
Trimethoprim—Eye disorder—Doxorubicin—ovarian cancer	0.000105	0.000911	CcSEcCtD
Trimethoprim—Tinnitus—Doxorubicin—ovarian cancer	0.000105	0.000909	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000105	0.000908	CcSEcCtD
Trimethoprim—Diarrhoea—Paclitaxel—ovarian cancer	0.000104	0.000896	CcSEcCtD
Trimethoprim—Immune system disorder—Doxorubicin—ovarian cancer	0.000102	0.000881	CcSEcCtD
Trimethoprim—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000102	0.000879	CcSEcCtD
Trimethoprim—Body temperature increased—Docetaxel—ovarian cancer	0.000101	0.000878	CcSEcCtD
Trimethoprim—Abdominal pain—Docetaxel—ovarian cancer	0.000101	0.000878	CcSEcCtD
Trimethoprim—Dizziness—Paclitaxel—ovarian cancer	0.0001	0.000866	CcSEcCtD
Trimethoprim—Mental disorder—Doxorubicin—ovarian cancer	9.87e-05	0.000854	CcSEcCtD
Trimethoprim—Erythema—Doxorubicin—ovarian cancer	9.81e-05	0.000849	CcSEcCtD
Trimethoprim—Malnutrition—Doxorubicin—ovarian cancer	9.81e-05	0.000849	CcSEcCtD
Trimethoprim—Agitation—Epirubicin—ovarian cancer	9.74e-05	0.000843	CcSEcCtD
Trimethoprim—Vomiting—Paclitaxel—ovarian cancer	9.62e-05	0.000833	CcSEcCtD
Trimethoprim—Rash—Paclitaxel—ovarian cancer	9.54e-05	0.000826	CcSEcCtD
Trimethoprim—Dermatitis—Paclitaxel—ovarian cancer	9.53e-05	0.000825	CcSEcCtD
Trimethoprim—Vertigo—Epirubicin—ovarian cancer	9.53e-05	0.000824	CcSEcCtD
Trimethoprim—Syncope—Epirubicin—ovarian cancer	9.51e-05	0.000823	CcSEcCtD
Trimethoprim—Leukopenia—Epirubicin—ovarian cancer	9.49e-05	0.000821	CcSEcCtD
Trimethoprim—Headache—Paclitaxel—ovarian cancer	9.48e-05	0.000821	CcSEcCtD
Trimethoprim—Hypersensitivity—Docetaxel—ovarian cancer	9.45e-05	0.000818	CcSEcCtD
Trimethoprim—Loss of consciousness—Epirubicin—ovarian cancer	9.32e-05	0.000806	CcSEcCtD
Trimethoprim—Cough—Epirubicin—ovarian cancer	9.25e-05	0.000801	CcSEcCtD
Trimethoprim—Convulsion—Epirubicin—ovarian cancer	9.19e-05	0.000795	CcSEcCtD
Trimethoprim—Pruritus—Docetaxel—ovarian cancer	9.08e-05	0.000785	CcSEcCtD
Trimethoprim—Myalgia—Epirubicin—ovarian cancer	9.03e-05	0.000781	CcSEcCtD
Trimethoprim—Arthralgia—Epirubicin—ovarian cancer	9.03e-05	0.000781	CcSEcCtD
Trimethoprim—Agitation—Doxorubicin—ovarian cancer	9.02e-05	0.00078	CcSEcCtD
Trimethoprim—Anxiety—Epirubicin—ovarian cancer	9e-05	0.000778	CcSEcCtD
Trimethoprim—Nausea—Paclitaxel—ovarian cancer	8.99e-05	0.000778	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	8.96e-05	0.000776	CcSEcCtD
Trimethoprim—Vertigo—Doxorubicin—ovarian cancer	8.81e-05	0.000763	CcSEcCtD
Trimethoprim—Syncope—Doxorubicin—ovarian cancer	8.8e-05	0.000761	CcSEcCtD
Trimethoprim—Leukopenia—Doxorubicin—ovarian cancer	8.78e-05	0.00076	CcSEcCtD
Trimethoprim—Diarrhoea—Docetaxel—ovarian cancer	8.78e-05	0.00076	CcSEcCtD
Trimethoprim—Confusional state—Epirubicin—ovarian cancer	8.73e-05	0.000755	CcSEcCtD
Trimethoprim—Anaphylactic shock—Epirubicin—ovarian cancer	8.65e-05	0.000749	CcSEcCtD
Trimethoprim—Loss of consciousness—Doxorubicin—ovarian cancer	8.62e-05	0.000746	CcSEcCtD
Trimethoprim—Cough—Doxorubicin—ovarian cancer	8.56e-05	0.000741	CcSEcCtD
Trimethoprim—Shock—Epirubicin—ovarian cancer	8.51e-05	0.000737	CcSEcCtD
Trimethoprim—Convulsion—Doxorubicin—ovarian cancer	8.5e-05	0.000736	CcSEcCtD
Trimethoprim—Nervous system disorder—Epirubicin—ovarian cancer	8.49e-05	0.000734	CcSEcCtD
Trimethoprim—Dizziness—Docetaxel—ovarian cancer	8.48e-05	0.000734	CcSEcCtD
Trimethoprim—Thrombocytopenia—Epirubicin—ovarian cancer	8.47e-05	0.000733	CcSEcCtD
Trimethoprim—Skin disorder—Epirubicin—ovarian cancer	8.41e-05	0.000727	CcSEcCtD
Trimethoprim—Myalgia—Doxorubicin—ovarian cancer	8.35e-05	0.000723	CcSEcCtD
Trimethoprim—Arthralgia—Doxorubicin—ovarian cancer	8.35e-05	0.000723	CcSEcCtD
Trimethoprim—Anxiety—Doxorubicin—ovarian cancer	8.32e-05	0.00072	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	8.29e-05	0.000718	CcSEcCtD
Trimethoprim—Anorexia—Epirubicin—ovarian cancer	8.25e-05	0.000714	CcSEcCtD
Trimethoprim—Vomiting—Docetaxel—ovarian cancer	8.16e-05	0.000706	CcSEcCtD
Trimethoprim—Rash—Docetaxel—ovarian cancer	8.09e-05	0.0007	CcSEcCtD
Trimethoprim—Dermatitis—Docetaxel—ovarian cancer	8.08e-05	0.000699	CcSEcCtD
Trimethoprim—Confusional state—Doxorubicin—ovarian cancer	8.07e-05	0.000699	CcSEcCtD
Trimethoprim—Headache—Docetaxel—ovarian cancer	8.04e-05	0.000695	CcSEcCtD
Trimethoprim—Anaphylactic shock—Doxorubicin—ovarian cancer	8.01e-05	0.000693	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Epirubicin—ovarian cancer	7.88e-05	0.000682	CcSEcCtD
Trimethoprim—Shock—Doxorubicin—ovarian cancer	7.88e-05	0.000682	CcSEcCtD
Trimethoprim—Nervous system disorder—Doxorubicin—ovarian cancer	7.85e-05	0.000679	CcSEcCtD
Trimethoprim—Thrombocytopenia—Doxorubicin—ovarian cancer	7.84e-05	0.000678	CcSEcCtD
Trimethoprim—Insomnia—Epirubicin—ovarian cancer	7.83e-05	0.000677	CcSEcCtD
Trimethoprim—Skin disorder—Doxorubicin—ovarian cancer	7.78e-05	0.000673	CcSEcCtD
Trimethoprim—Dyspnoea—Epirubicin—ovarian cancer	7.71e-05	0.000668	CcSEcCtD
Trimethoprim—Anorexia—Doxorubicin—ovarian cancer	7.63e-05	0.00066	CcSEcCtD
Trimethoprim—Nausea—Docetaxel—ovarian cancer	7.62e-05	0.000659	CcSEcCtD
Trimethoprim—Dyspepsia—Epirubicin—ovarian cancer	7.62e-05	0.000659	CcSEcCtD
Trimethoprim—Decreased appetite—Epirubicin—ovarian cancer	7.52e-05	0.000651	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Epirubicin—ovarian cancer	7.47e-05	0.000646	CcSEcCtD
Trimethoprim—Constipation—Epirubicin—ovarian cancer	7.4e-05	0.00064	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	7.29e-05	0.000631	CcSEcCtD
Trimethoprim—Insomnia—Doxorubicin—ovarian cancer	7.24e-05	0.000627	CcSEcCtD
Trimethoprim—Dyspnoea—Doxorubicin—ovarian cancer	7.14e-05	0.000618	CcSEcCtD
Trimethoprim—Feeling abnormal—Epirubicin—ovarian cancer	7.13e-05	0.000617	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Epirubicin—ovarian cancer	7.08e-05	0.000612	CcSEcCtD
Trimethoprim—Dyspepsia—Doxorubicin—ovarian cancer	7.05e-05	0.00061	CcSEcCtD
Trimethoprim—Decreased appetite—Doxorubicin—ovarian cancer	6.96e-05	0.000602	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Doxorubicin—ovarian cancer	6.91e-05	0.000598	CcSEcCtD
Trimethoprim—Urticaria—Epirubicin—ovarian cancer	6.87e-05	0.000595	CcSEcCtD
Trimethoprim—Constipation—Doxorubicin—ovarian cancer	6.85e-05	0.000593	CcSEcCtD
Trimethoprim—Body temperature increased—Epirubicin—ovarian cancer	6.84e-05	0.000592	CcSEcCtD
Trimethoprim—Abdominal pain—Epirubicin—ovarian cancer	6.84e-05	0.000592	CcSEcCtD
Trimethoprim—Feeling abnormal—Doxorubicin—ovarian cancer	6.6e-05	0.000571	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Doxorubicin—ovarian cancer	6.55e-05	0.000567	CcSEcCtD
Trimethoprim—DHFR—Cell Cycle—CCNE1—ovarian cancer	6.53e-05	0.00123	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	6.51e-05	0.00122	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—CCND2—ovarian cancer	6.5e-05	0.00122	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—BRCA1—ovarian cancer	6.5e-05	0.00122	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—BIRC5—ovarian cancer	6.45e-05	0.00121	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	6.44e-05	0.00121	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—TYMS—ovarian cancer	6.41e-05	0.0012	CbGpPWpGaD
Trimethoprim—Hypersensitivity—Epirubicin—ovarian cancer	6.38e-05	0.000552	CcSEcCtD
Trimethoprim—TYMS—Cell Cycle, Mitotic—CCNE1—ovarian cancer	6.37e-05	0.0012	CbGpPWpGaD
Trimethoprim—Urticaria—Doxorubicin—ovarian cancer	6.36e-05	0.00055	CcSEcCtD
Trimethoprim—Abdominal pain—Doxorubicin—ovarian cancer	6.33e-05	0.000548	CcSEcCtD
Trimethoprim—Body temperature increased—Doxorubicin—ovarian cancer	6.33e-05	0.000548	CcSEcCtD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	6.28e-05	0.00118	CbGpPWpGaD
Trimethoprim—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ovarian cancer	6.25e-05	0.00117	CbGpPWpGaD
Trimethoprim—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	6.22e-05	0.00117	CbGpPWpGaD
Trimethoprim—DHFR—Disease—HDAC6—ovarian cancer	6.19e-05	0.00116	CbGpPWpGaD
Trimethoprim—CYP2C8—Biological oxidations—CYP1B1—ovarian cancer	6.15e-05	0.00116	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—PPP2R1A—ovarian cancer	6.13e-05	0.00115	CbGpPWpGaD
Trimethoprim—Pruritus—Epirubicin—ovarian cancer	6.12e-05	0.00053	CcSEcCtD
Trimethoprim—CYP2C8—Metapathway biotransformation—CYP1B1—ovarian cancer	6.07e-05	0.00114	CbGpPWpGaD
Trimethoprim—TYMS—Circadian rythm related genes—PTEN—ovarian cancer	6.03e-05	0.00113	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—BRIP1—ovarian cancer	5.97e-05	0.00112	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PPP1CC—ovarian cancer	5.97e-05	0.00112	CbGpPWpGaD
Trimethoprim—Diarrhoea—Epirubicin—ovarian cancer	5.92e-05	0.000512	CcSEcCtD
Trimethoprim—Hypersensitivity—Doxorubicin—ovarian cancer	5.9e-05	0.00051	CcSEcCtD
Trimethoprim—TYMS—Cell Cycle—BRCA2—ovarian cancer	5.88e-05	0.0011	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—BIRC5—ovarian cancer	5.76e-05	0.00108	CbGpPWpGaD
Trimethoprim—Dizziness—Epirubicin—ovarian cancer	5.72e-05	0.000495	CcSEcCtD
Trimethoprim—TYMS—Cell Cycle—CCNE1—ovarian cancer	5.69e-05	0.00107	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	5.67e-05	0.00107	CbGpPWpGaD
Trimethoprim—Pruritus—Doxorubicin—ovarian cancer	5.66e-05	0.00049	CcSEcCtD
Trimethoprim—TYMS—Cell Cycle, Mitotic—BIRC5—ovarian cancer	5.62e-05	0.00106	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—TERT—ovarian cancer	5.58e-05	0.00105	CbGpPWpGaD
Trimethoprim—Vomiting—Epirubicin—ovarian cancer	5.5e-05	0.000476	CcSEcCtD
Trimethoprim—Diarrhoea—Doxorubicin—ovarian cancer	5.48e-05	0.000474	CcSEcCtD
Trimethoprim—Rash—Epirubicin—ovarian cancer	5.46e-05	0.000472	CcSEcCtD
Trimethoprim—Dermatitis—Epirubicin—ovarian cancer	5.45e-05	0.000472	CcSEcCtD
Trimethoprim—Headache—Epirubicin—ovarian cancer	5.42e-05	0.000469	CcSEcCtD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	5.41e-05	0.00102	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	5.37e-05	0.00101	CbGpPWpGaD
Trimethoprim—DHFR—Disease—XIAP—ovarian cancer	5.36e-05	0.00101	CbGpPWpGaD
Trimethoprim—Dizziness—Doxorubicin—ovarian cancer	5.29e-05	0.000458	CcSEcCtD
Trimethoprim—DHFR—Disease—SMARCA4—ovarian cancer	5.23e-05	0.000982	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	5.22e-05	0.00098	CbGpPWpGaD
Trimethoprim—Nausea—Epirubicin—ovarian cancer	5.14e-05	0.000445	CcSEcCtD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	5.1e-05	0.000959	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	5.1e-05	0.000959	CbGpPWpGaD
Trimethoprim—DHFR—Disease—EREG—ovarian cancer	5.1e-05	0.000959	CbGpPWpGaD
Trimethoprim—Vomiting—Doxorubicin—ovarian cancer	5.09e-05	0.000441	CcSEcCtD
Trimethoprim—Rash—Doxorubicin—ovarian cancer	5.05e-05	0.000437	CcSEcCtD
Trimethoprim—Dermatitis—Doxorubicin—ovarian cancer	5.04e-05	0.000436	CcSEcCtD
Trimethoprim—TYMS—Cell Cycle—BIRC5—ovarian cancer	5.03e-05	0.000945	CbGpPWpGaD
Trimethoprim—Headache—Doxorubicin—ovarian cancer	5.02e-05	0.000434	CcSEcCtD
Trimethoprim—CYP2C9—Biological oxidations—CYP1B1—ovarian cancer	5.01e-05	0.000941	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	4.95e-05	0.000929	CbGpPWpGaD
Trimethoprim—CYP2C9—Metapathway biotransformation—CYP1B1—ovarian cancer	4.94e-05	0.000928	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—TERT—ovarian cancer	4.87e-05	0.000915	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	4.82e-05	0.000906	CbGpPWpGaD
Trimethoprim—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ovarian cancer	4.78e-05	0.000898	CbGpPWpGaD
Trimethoprim—Nausea—Doxorubicin—ovarian cancer	4.76e-05	0.000412	CcSEcCtD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	4.74e-05	0.000891	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	4.63e-05	0.000871	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—YAP1—ovarian cancer	4.59e-05	0.000862	CbGpPWpGaD
Trimethoprim—DHFR—Disease—FASN—ovarian cancer	4.46e-05	0.000839	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PARP1—ovarian cancer	4.45e-05	0.000835	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	4.43e-05	0.000832	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—CXCL8—ovarian cancer	4.37e-05	0.00082	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	4.29e-05	0.000805	CbGpPWpGaD
Trimethoprim—DHFR—Disease—SLC2A1—ovarian cancer	4.24e-05	0.000797	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	4.19e-05	0.000788	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—AQP3—ovarian cancer	4.18e-05	0.000785	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—CASP3—ovarian cancer	4.18e-05	0.000785	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—IL2—ovarian cancer	4.17e-05	0.000784	CbGpPWpGaD
Trimethoprim—TYMS—Circadian rythm related genes—TP53—ovarian cancer	4.11e-05	0.000773	CbGpPWpGaD
Trimethoprim—ABCB1—HIF-1-alpha transcription factor network—VEGFA—ovarian cancer	4.09e-05	0.000769	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	4.06e-05	0.000763	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	4.01e-05	0.000753	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—YAP1—ovarian cancer	4e-05	0.000752	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	3.99e-05	0.000749	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	3.86e-05	0.000726	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	3.78e-05	0.000711	CbGpPWpGaD
Trimethoprim—TYMS—Circadian rythm related genes—IL6—ovarian cancer	3.77e-05	0.000708	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—NME2—ovarian cancer	3.75e-05	0.000705	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—FASN—ovarian cancer	3.74e-05	0.000702	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—SLC5A5—ovarian cancer	3.68e-05	0.000691	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	3.62e-05	0.00068	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—CCND1—ovarian cancer	3.61e-05	0.000678	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PPP2R1A—ovarian cancer	3.61e-05	0.000678	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—SLC2A1—ovarian cancer	3.55e-05	0.000667	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—VEGFA—ovarian cancer	3.55e-05	0.000666	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—CYP1B1—ovarian cancer	3.4e-05	0.00064	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—CDKN1B—ovarian cancer	3.38e-05	0.000636	CbGpPWpGaD
Trimethoprim—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	3.3e-05	0.000621	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	3.3e-05	0.00062	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—NME2—ovarian cancer	3.27e-05	0.000614	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—FASN—ovarian cancer	3.26e-05	0.000613	CbGpPWpGaD
Trimethoprim—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	3.26e-05	0.000612	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—CCND1—ovarian cancer	3.23e-05	0.000606	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—SLC5A5—ovarian cancer	3.21e-05	0.000603	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	3.18e-05	0.000598	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	3.17e-05	0.000595	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—CCND1—ovarian cancer	3.15e-05	0.000592	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—SLC2A1—ovarian cancer	3.1e-05	0.000582	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	3.1e-05	0.000582	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—NME2—ovarian cancer	3.05e-05	0.000574	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PPP2R1A—ovarian cancer	3.02e-05	0.000567	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—MAPK3—ovarian cancer	2.98e-05	0.000559	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—CYP1B1—ovarian cancer	2.97e-05	0.000558	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—CDKN1B—ovarian cancer	2.95e-05	0.000555	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	2.93e-05	0.00055	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—MYC—ovarian cancer	2.9e-05	0.000544	CbGpPWpGaD
Trimethoprim—DHFR—Disease—TERT—ovarian cancer	2.86e-05	0.000538	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—MAPK1—ovarian cancer	2.83e-05	0.000532	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—CCND1—ovarian cancer	2.82e-05	0.000529	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—ABCB1—ovarian cancer	2.8e-05	0.000527	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—TYMS—ovarian cancer	2.75e-05	0.000517	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—MAPK3—ovarian cancer	2.66e-05	0.0005	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CAV1—ovarian cancer	2.65e-05	0.000498	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PPP2R1A—ovarian cancer	2.63e-05	0.000495	CbGpPWpGaD
Trimethoprim—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	2.61e-05	0.000491	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—MAPK3—ovarian cancer	2.6e-05	0.000488	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	2.59e-05	0.000487	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	2.59e-05	0.000487	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—MYC—ovarian cancer	2.59e-05	0.000486	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—MAPK1—ovarian cancer	2.53e-05	0.000476	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—MYC—ovarian cancer	2.53e-05	0.000475	CbGpPWpGaD
Trimethoprim—DHFR—Disease—IL6ST—ovarian cancer	2.51e-05	0.000472	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—MAPK1—ovarian cancer	2.47e-05	0.000464	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—ABCB1—ovarian cancer	2.45e-05	0.00046	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CYTB—ovarian cancer	2.42e-05	0.000454	CbGpPWpGaD
Trimethoprim—DHFR—Disease—APC—ovarian cancer	2.41e-05	0.000453	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.36e-05	0.000444	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—MAPK3—ovarian cancer	2.32e-05	0.000436	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	2.27e-05	0.000427	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—MYC—ovarian cancer	2.26e-05	0.000424	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—CAV1—ovarian cancer	2.22e-05	0.000417	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—MAPK1—ovarian cancer	2.21e-05	0.000415	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—TP53—ovarian cancer	2.13e-05	0.000399	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PIK3CD—ovarian cancer	2.12e-05	0.000399	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.11e-05	0.000397	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—BRIP1—ovarian cancer	2.11e-05	0.000397	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PPP1CC—ovarian cancer	2.11e-05	0.000397	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	2.11e-05	0.000397	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CYTB—ovarian cancer	2.11e-05	0.000396	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	2.1e-05	0.000395	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	2.06e-05	0.000387	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.04e-05	0.000384	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PIK3CG—ovarian cancer	2.02e-05	0.00038	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—NME2—ovarian cancer	2.01e-05	0.000378	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	2.01e-05	0.000377	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.99e-05	0.000374	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CYTB—ovarian cancer	1.97e-05	0.00037	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.94e-05	0.000364	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—CAV1—ovarian cancer	1.94e-05	0.000364	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.92e-05	0.000361	CbGpPWpGaD
Trimethoprim—DHFR—Disease—ERBB2—ovarian cancer	1.87e-05	0.000352	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—TP53—ovarian cancer	1.85e-05	0.000349	CbGpPWpGaD
Trimethoprim—DHFR—Disease—MTOR—ovarian cancer	1.85e-05	0.000347	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PIK3CB—ovarian cancer	1.85e-05	0.000347	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PPP1CC—ovarian cancer	1.84e-05	0.000346	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—BRIP1—ovarian cancer	1.84e-05	0.000346	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PIK3CD—ovarian cancer	1.78e-05	0.000334	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PIK3CG—ovarian cancer	1.76e-05	0.000331	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.75e-05	0.000329	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CDKN1B—ovarian cancer	1.74e-05	0.000326	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—BRIP1—ovarian cancer	1.72e-05	0.000323	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PPP1CC—ovarian cancer	1.72e-05	0.000323	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.66e-05	0.000311	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CTNNB1—ovarian cancer	1.64e-05	0.000308	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.61e-05	0.000303	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PTEN—ovarian cancer	1.6e-05	0.0003	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.58e-05	0.000296	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.57e-05	0.000296	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PIK3CD—ovarian cancer	1.55e-05	0.000291	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PIK3CB—ovarian cancer	1.55e-05	0.000291	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.54e-05	0.000289	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.49e-05	0.00028	CbGpPWpGaD
Trimethoprim—DHFR—Disease—STAT3—ovarian cancer	1.43e-05	0.000269	CbGpPWpGaD
Trimethoprim—DHFR—Disease—NRAS—ovarian cancer	1.43e-05	0.000268	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—YAP1—ovarian cancer	1.42e-05	0.000266	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.4e-05	0.000264	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	1.37e-05	0.000257	CbGpPWpGaD
Trimethoprim—DHFR—Disease—MAPK3—ovarian cancer	1.37e-05	0.000257	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PIK3CB—ovarian cancer	1.35e-05	0.000254	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PTEN—ovarian cancer	1.34e-05	0.000251	CbGpPWpGaD
Trimethoprim—DHFR—Disease—MYC—ovarian cancer	1.33e-05	0.00025	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	1.32e-05	0.000248	CbGpPWpGaD
Trimethoprim—DHFR—Disease—MAPK1—ovarian cancer	1.3e-05	0.000244	CbGpPWpGaD
Trimethoprim—DHFR—Disease—EGFR—ovarian cancer	1.3e-05	0.000244	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CYTB—ovarian cancer	1.3e-05	0.000244	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.25e-05	0.000235	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—YAP1—ovarian cancer	1.23e-05	0.000232	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.23e-05	0.000232	CbGpPWpGaD
Trimethoprim—DHFR—Disease—KRAS—ovarian cancer	1.23e-05	0.000231	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PTEN—ovarian cancer	1.17e-05	0.000219	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—FASN—ovarian cancer	1.16e-05	0.000217	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—YAP1—ovarian cancer	1.15e-05	0.000217	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.14e-05	0.000214	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—SLC5A5—ovarian cancer	1.14e-05	0.000214	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PPP1CC—ovarian cancer	1.13e-05	0.000213	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—BRIP1—ovarian cancer	1.13e-05	0.000213	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PIK3CA—ovarian cancer	1.13e-05	0.000212	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	1.12e-05	0.00021	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—SLC2A1—ovarian cancer	1.1e-05	0.000206	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.07e-05	0.000202	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CYP1B1—ovarian cancer	1.05e-05	0.000198	CbGpPWpGaD
Trimethoprim—DHFR—Disease—HRAS—ovarian cancer	1.04e-05	0.000196	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—FASN—ovarian cancer	1.01e-05	0.000189	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1e-05	0.000189	CbGpPWpGaD
Trimethoprim—DHFR—Disease—IL6—ovarian cancer	9.98e-06	0.000188	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—SLC5A5—ovarian cancer	9.9e-06	0.000186	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—SLC2A1—ovarian cancer	9.56e-06	0.00018	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PIK3CA—ovarian cancer	9.44e-06	0.000177	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—FASN—ovarian cancer	9.4e-06	0.000177	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	9.33e-06	0.000175	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	9.29e-06	0.000174	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—SLC5A5—ovarian cancer	9.25e-06	0.000174	CbGpPWpGaD
Trimethoprim—DHFR—Disease—AKT1—ovarian cancer	9.21e-06	0.000173	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CYP1B1—ovarian cancer	9.17e-06	0.000172	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—SLC2A1—ovarian cancer	8.93e-06	0.000168	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	8.75e-06	0.000164	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ABCB1—ovarian cancer	8.66e-06	0.000163	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CYP1B1—ovarian cancer	8.56e-06	0.000161	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—TYMS—ovarian cancer	8.51e-06	0.00016	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PIK3CA—ovarian cancer	8.24e-06	0.000155	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PPP2R1A—ovarian cancer	8.13e-06	0.000153	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—AKT1—ovarian cancer	7.71e-06	0.000145	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—YAP1—ovarian cancer	7.61e-06	0.000143	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	7.59e-06	0.000143	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	7.56e-06	0.000142	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—TYMS—ovarian cancer	7.41e-06	0.000139	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ABCB1—ovarian cancer	7.05e-06	0.000133	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—TYMS—ovarian cancer	6.93e-06	0.00013	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CAV1—ovarian cancer	6.86e-06	0.000129	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—AKT1—ovarian cancer	6.73e-06	0.000126	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	6.55e-06	0.000123	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PIK3CG—ovarian cancer	6.25e-06	0.000117	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—FASN—ovarian cancer	6.2e-06	0.000117	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—SLC5A5—ovarian cancer	6.1e-06	0.000115	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CAV1—ovarian cancer	5.97e-06	0.000112	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—SLC2A1—ovarian cancer	5.89e-06	0.000111	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CYP1B1—ovarian cancer	5.65e-06	0.000106	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CAV1—ovarian cancer	5.58e-06	0.000105	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PIK3CD—ovarian cancer	5.49e-06	0.000103	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PIK3CG—ovarian cancer	5.44e-06	0.000102	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.33e-06	0.0001	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PIK3CG—ovarian cancer	5.08e-06	9.55e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	5.01e-06	9.41e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PIK3CB—ovarian cancer	4.79e-06	8.99e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PIK3CD—ovarian cancer	4.78e-06	8.99e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ABCB1—ovarian cancer	4.65e-06	8.74e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—TYMS—ovarian cancer	4.57e-06	8.58e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PIK3CD—ovarian cancer	4.47e-06	8.4e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PIK3CB—ovarian cancer	4.17e-06	7.83e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PTEN—ovarian cancer	4.14e-06	7.77e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PIK3CB—ovarian cancer	3.9e-06	7.32e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CAV1—ovarian cancer	3.68e-06	6.92e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PTEN—ovarian cancer	3.6e-06	6.77e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PTEN—ovarian cancer	3.37e-06	6.32e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PIK3CG—ovarian cancer	3.35e-06	6.3e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PIK3CD—ovarian cancer	2.95e-06	5.54e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PIK3CA—ovarian cancer	2.92e-06	5.48e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PIK3CB—ovarian cancer	2.57e-06	4.83e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PIK3CA—ovarian cancer	2.54e-06	4.78e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—AKT1—ovarian cancer	2.38e-06	4.48e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PIK3CA—ovarian cancer	2.37e-06	4.46e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PTEN—ovarian cancer	2.22e-06	4.17e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—AKT1—ovarian cancer	2.08e-06	3.9e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—AKT1—ovarian cancer	1.94e-06	3.64e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.57e-06	2.94e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—AKT1—ovarian cancer	1.28e-06	2.4e-05	CbGpPWpGaD
